Product Program year 2024 Source: CMS Open Payments

Vowst

Drug Internal Medicine Infection Disease

NDC 71881-400-12

Open in the dashboard

General payments

$5,276

19 payments

Research payments

$133,746

52 payments

Through program year 2024, $5,276 in general payments and $133,746 in research payments were reported against Vowst (Internal Medicine Infection Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $1,527 7
2024 Research $40,865 15
2023 General $3,748 12
2023 Research $92,881 37

Breakdown

Who paid General payments · program years 2023–2024
  1. Seres Therapeutics, Inc. $5,276 19 payments
Top recipients General payments · program year 2024
  1. Elizabeth Ghera Nurse Practitioner, Pediatrics · Burr Ridge, IL $1,080 71% · 1 payment
  2. Carl Crawford Gastroenterology · New York, NY $118 8% · 1 payment
  3. Tiffany Min Nurse Practitioner, Acute Care · New York, NY $118 8% · 1 payment
  4. Sybil Olmo Nurse Practitioner, Family · Ridgewood, NY $118 8% · 1 payment
  5. Doris Ponce Hematology & Oncology · New York, NY $50 3% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Nurse Practitioner, Pediatrics Nurse Practitioner $1,080 71% · 1 practitioner
  2. Gastroenterology Internal Medicine $161 11% · 3 practitioners
  3. Nurse Practitioner, Acute Care Nurse Practitioner $118 8% · 1 practitioner
  4. Nurse Practitioner, Family Nurse Practitioner $118 8% · 1 practitioner
  5. Hematology & Oncology Internal Medicine $50 3% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Illinois $1,080 71% · 1 recipient
  2. New York $437 29% · 5 recipients
  3. Connecticut $10 <1% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

19 general · 52 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record